Bitterroot Bio Completes Phase 1 Study Enrollment for BRB-002
29 Oct 2024 //
GLOBENEWSWIRE
Bitterroot Bio: Appoints Georgette Verdin As CPO, Sherwin Chen As CLO/Secretary
04 Jun 2024 //
GLOBENEWSWIRE
Bitterroot Bio Doses First Participants in BRB-002 Phase 1 Study
29 Apr 2024 //
GLOBENEWSWIRE
Bitterroot Bio and Biotheus Announce Research Collaboration
26 Feb 2024 //
GLOBENEWSWIRE
Bitterroot Bio to Present Research at American Heart Association Conference
30 Oct 2023 //
GLOBENEWSWIRE
Bitterroot Bio Launches Out of Stealth with $145 Million Series A Financing
07 Jun 2023 //
GLOBENEWSWIRE